Sponsored Breakfast Symposia

Friday 15th June 2018

Presentation Title: How does new data inform our approach to acute and chronic management of Acute Coronary Syndrome?
Time: 0725 - 0740 Breakfast Served
          0740 - 0840 Symposium
NB: Transportation to the venue will be provided from the accommodation venues, exact schedule to be advised closer to the Meeting
Room: Brevet Lounge              
Chair & Speaker: Associate Professor Gerry Devlin, Waikato Hospital
Speaker: Professor Stephen Nicholls, South Australian Health & Medical Research Institute

Synopsis:
An overview of some recent data presented in the Acute Coronary Syndrome patient population, practical application for both acute and chronic management strategies, with patient case studies

 

Presentation Title: CHALLENGING THE PARADIGM: Entresto® (sacubitril/valsartan) in systolic heart failure
Time: 0725 - 0740 Breakfast Served
           0740 - 0840 Symposium
NB: Transportation to the venue will be provided from the accommodation venues, exact schedule to be advised closer to the Meeting
Room: Morrison Room 
Speakers: Professor Richard Troughton, Christchurch Heart Institute & Professor Peter Macdonald  

Topic 1: HFrEF and Neurohormonal Systems 
Topic 2: Key Results from PARADIGM-HF 
Topic 3: Sacubitril/valsartan clinical experience & case studies 

 

Saturday 16th June 2018

Philips

Presentation Title: SYNTAX II: A State-of-the-Art Approach to Managing PCI
Time: 0730 - 0745 Breakfast Served
           0745 - 0845 Symposium
NB: Transportation to the venue will be provided from the accommodation venues, exact schedule to be advised closer to the Meeting
Room: Morrison Room                
Moderator and Speaker:  Dr David Smyth, Christchurch Hospital
Speakers: Dr Aniket Puri, Christchurch Hospital & Dr Rajesh Nair, Waikato Hospital

Topic 1: SYNTAX II: A State-of-the-Art Approach to Managing PCI 
Topic 2: The Critical Role of Physiology in State-of-the-Art PCI 
Topic 3: The Critical Role of IVUS in State-of-the-Art PCI 

Synopsis:
This session will address
  • The key outcomes of the Syntax II Trial and understand the clinical implications of this data
  • Incorporating State-of-the-art technologies and procedural techniques to improve clinical outcomes in complex
   revascularisation
  • Recognising the critical role of iFR and IVUS in simplifying decision making and providing confidence in treatment
  • Expected benefits on health economics and patient outcomes derived from contemporary PCI practice       

 

Presentation Title: Critical appraisal of PCSK9 antibody trials: the ODYSSEY journey and implications for clinical practice
Time: 0730 - 0745 Breakfast Served
           0745 - 0845 Symposium
NB: Transportation to the venue will be provided from the accommodation venues, exact schedule to be advised closer to the Meeting
Room: Brevet Lounge              
Speaker:  Professor Harvey White, Auckland City Hospital

© 2018 CSANZ | Conference is managed by The Conference Company

Designed & Developed by 72DPI